A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
Clinical trial NCT03322566 · COMPLETED
Trial details
- NCT number
- NCT03322566
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2018-12-13
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.